ELAN Performance: 155.3% Return (12 Months)

ELAN returned 155.3% over 12 months, outperforming the S&P 500 (32.1%). Volatility: 51.9%.

RS IBD 65.76
Top 29% in Peers
Volatility 51.9%
Top 50% in Peers
Total Return 12m 155.26%
Top 18% in Peers
RS Rating 86.69
Top 29% in Peers
P/E
P/E Trailing 0.00
P/E Forward 22.2
High / Low 52w
52 Week High 26.84 USD
52 Week Low 8.10 USD
Sentiment
VRO Trend Strength ±100 11.97
Buy Signal ±3 -0.12
Drawdowns 3y
Max Drawdown 56.10%
Mean Drawdown 15.20%
Compare performance with 81 peers in Pharmaceuticals
12m Total Return: ELAN (155.3%) vs PEER ETF Total Return of Elanco Animal Health versus broad market ETF SPY
5y Drawdown (Underwater) Chart 5 Year Drawdown / Underwater Chart for ELAN Performance: 155.3% Return (12 Months)

Top Performer in Pharmaceuticals (5/81)

Short Term Performance
SYMBOL 1W 1M 3M
ELVN 6.42% 32.27% 157.20%
IRD 5.98% -5.73% 121.63%
NKTR 14.51% 5.69% 73.89%
RLMD 8.15% 55.06% 69.12%
ETON 10.72% 48.81% 50.88%
ELAN -2.65% -2.31% -4.12%
Long Term Performance
SYMBOL 6M 12M 5Y
RLMD 231.73% 2552.83% -80.81%
TERN 526.10% 2539.00% 187.16%
NKTR 24.68% 915.77% -74.11%
ANRO 244.50% 896.90% 40.81%
BIOA 211.37% 444.41% -4.26%
ELAN 10.45% 155.26% -22.91%
Overall Best Picks of Peer Group (GARP Metrics)
SYMBOL MCAP 1M 12M 5Y P/E P/E fwd PEG EPS stab EPS cagr
MRK NYSE
Merck		 299B 5.14% 54.3% 96.4% 16.6 23.5 3.68 20.7% -1.27%
NVS NYSE
Novartis		 297B -1.64% 53.1% 112% 21.5 17.2 2.69 89.2% 9.19%
GSK NYSE
GlaxoSmithKline		 113B 3.41% 68.3% 90.8% 15.5 22.4 0.50 -17.9% -45.1%
IPN PA
Ipsen		 15.9B 4.10% 73.2% 131% 31.5 17.5 1.22 -15.1% -46.2%
RPRX NASDAQ
Royalty Pharma		 28.1B 4.21% 56.1% 26.8% 27.3 29.8 2.78 -23.5% -44.0%
JNJ NYSE
Johnson & Johnson		 586B 0.24% 64.4% 70.3% 22.0 21.1 1.71 12.4% -2.16%
AZN NASDAQ
AstraZeneca		 315B 4.43% 56.9% 128% 31.2 19.3 1.65 71.9% 104%
INVA NASDAQ
Innoviva		 1.66B 4.49% 31.5% 93.6% 13.4 12.1 0.35 0.60% -1.26%

Performance: ELAN vs S&P 500

Total Return vs S&P 500
PERIOD ELAN S&P 500 DIFFERENCE
1 Month -2.31% -1.73% -0.59%
3 Months -4.12% -4.49% 0.39%
6 Months 10.45% -1.33% 11.94%
12 Months 155.26% 32.14% 93.17%
5 Years -22.91% 72.70% -55.36%

ELAN Performance FAQ

Does ELAN outperform the market?

Yes, ELAN significantly outperforms the market. Over the past 12 months, ELAN returned 155.26% compared to 32.14% for the S&P 500.

What is the ELAN return over the last 12 months?

ELAN has returned 155.26% over the past 12 months, including dividends. Over 3 months the return was -4.12%, and over 5 years -22.91%.

How risky is ELAN?

ELAN has relatively low risk with a maximum drawdown of 56.10% over the past 3 years. The average drawdown is 15.20%.

ELAN vs Sectors (12m)

Sorted by outperformance. Positive = ELAN beats sector.

Relative Performance vs S&P Sectors
SECTOR ETF DIFFERENCE 12M
Consumer Staples XLP 145.7%
Health Care XLV 144.5%
Real Estate XLRE 141.6%
Financials XLF 140.4%
Consumer Discretionary XLY 133.6%
Consumer Discretionary XLY 133.6%
Communication Services XLC 125.7%
Materials XLB 121.6%
Industrials XLI 113.2%
Technology XLK 105.3%
Energy XLE 97.8%

ELAN vs Asset Classes (12m)

Relative Performance vs Major Asset Classes
ASSET CLASS ETF DIFFERENCE 12M
S&P 500 SPY 93.17%
Gold GLD 99%
Long-Term Bonds TLT 154.7%